- 5 Résultats
prix le plus bas: € 69,90, prix le plus élevé: € 275,18, prix moyen: € 160,49
1
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer / Michail Ignatiadis (u. a.) / Buch / Recent Results in Cancer Research / Englisch / 2012 / Springer-Verlag GmbH - Ignatiadis, Michail
Commander
sur booklooker.de
€ 69,90
CommanderLien sponsorisé
Ignatiadis, Michail:

Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer / Michail Ignatiadis (u. a.) / Buch / Recent Results in Cancer Research / Englisch / 2012 / Springer-Verlag GmbH - edition reliée, livre de poche

2012, ISBN: 9783642281594

[ED: Gebunden], [PU: Springer-Verlag GmbH], Most deaths from carcinomas are caused by the hematogenous dissemination of cancer cells to distant organs and the eventual development of meta… Plus…

Frais d'envoiZzgl. Versandkosten., Livraison non-comprise Buchbär
2
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer / Michail Ignatiadis (u. a.) / Buch / Recent Results in Cancer Research / HC runder Rücken kaschiert / XIV / Englisch / 2012 - Ignatiadis, Michail
Commander
sur booklooker.de
€ 144,74
Envoi: € 0,001
CommanderLien sponsorisé

Ignatiadis, Michail:

Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer / Michail Ignatiadis (u. a.) / Buch / Recent Results in Cancer Research / HC runder Rücken kaschiert / XIV / Englisch / 2012 - edition reliée, livre de poche

2012, ISBN: 9783642281594

[ED: Gebunden], [PU: Springer-Verlag GmbH], This important book provides up-to-date information on a series of topical issues relating to the approach to minimal residual disease in breas… Plus…

Frais d'envoiVersandkostenfrei, Versand nach Deutschland. (EUR 0.00) Buchbär
3
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer - Ignatiadis, Michail (Herausgeber); Pantel, Klaus (Herausgeber); Sotiriou, Christos (Herausgeber)
Commander
sur Achtung-Buecher.de
€ 162,49
Envoi: € 0,001
CommanderLien sponsorisé
Ignatiadis, Michail (Herausgeber); Pantel, Klaus (Herausgeber); Sotiriou, Christos (Herausgeber):
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer - edition reliée, livre de poche

2012

ISBN: 3642281591

2012 Gebundene Ausgabe Brust / Mammakarzinom, Brustkrebs, Krebs (Krankheit) / Brustkrebs, Krebs (Krankheit) / Mammakarzinom, Frauenarzt, Frauenheilkunde, Gynäkologie - Gynäkologe, Krebs… Plus…

Frais d'envoiSans frais d'envoi en Allemagne. (EUR 0.00) MARZIES.de Buch- und Medienhandel, 14621 Schönwalde-Glien
4
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer - Ignatiadis, Michail (EDT); Sotiriou, Christos (EDT); Pantel, Klaus (EDT)
Commander
sur AbeBooks.fr
€ 275,18
Envoi: € 14,591
CommanderLien sponsorisé
Ignatiadis, Michail (EDT); Sotiriou, Christos (EDT); Pantel, Klaus (EDT):
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer - edition reliée, livre de poche

2012, ISBN: 3642281591

[EAN: 9783642281594], D'occasion, comme neuf, [SC: 14.59], [PU: Springer], Unread book in perfect condition., Books

NOT NEW BOOK. Frais d'envoi EUR 14.59 GreatBookPrices, Columbia, MD, U.S.A. [5352716] [Note: 5 (sur 5)]
5
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer - Ignatiadis, Michail (EDT); Sotiriou, Christos (EDT); Pantel, Klaus (EDT)
Commander
sur AbeBooks.fr
€ 150,16
Envoi: € 14,591
CommanderLien sponsorisé
Ignatiadis, Michail (EDT); Sotiriou, Christos (EDT); Pantel, Klaus (EDT):
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer - edition reliée, livre de poche

2012, ISBN: 3642281591

[EAN: 9783642281594], Nouveau livre, [SC: 14.59], [PU: Springer], Books

NEW BOOK. Frais d'envoi EUR 14.59 GreatBookPrices, Columbia, MD, U.S.A. [5352716] [Note: 5 (sur 5)]

1Comme certaines plateformes ne transmettent pas les conditions d'expédition et que celles-ci peuvent dépendre du pays de livraison, du prix d'achat, du poids et de la taille de l'article, d'une éventuelle adhésion de la plateforme, d'une livraison directe par la plateforme ou via un prestataire tiers (Marketplace), etc. il est possible que les frais de livraison indiqués par eurolivre ne correspondent pas à ceux de la plateforme qui propose l'article.

Données bibliographiques du meilleur livre correspondant

Détails sur le livre
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer

This important book provides up-to-date information on a series of topical issues relating to the approach to minimal residual disease in breast cancer patients. It first explains how the study of minimal residual disease and circulating and disseminated tumor cells (CTCs/DTCs) can assist in the understanding of breast cancer metastasis. A series of chapters then discuss the various technologies available for the detection and characterization of CTCs and DTCs, pinpointing their merits and limitations. Detailed consideration is given to the relevance of CTCs and DTCs, and their detection, to clinical research and practice. The role of other blood-based biomarkers is also addressed, and the closing chapters debate the challenges facing drug and biomarker co-development and the use of CTCs for companion diagnostic development. This book will be of interest and assistance to all who are engaged in the modern management of breast cancer.

Informations détaillées sur le livre - Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer


EAN (ISBN-13): 9783642281594
ISBN (ISBN-10): 3642281591
Version reliée
Date de parution: 2012
Editeur: Springer Berlin
253 Pages
Poids: 0,540 kg
Langue: Englisch

Livre dans la base de données depuis 2007-07-25T05:23:28+02:00 (Paris)
Page de détail modifiée en dernier sur 2024-02-11T15:46:20+01:00 (Paris)
ISBN/EAN: 3642281591

ISBN - Autres types d'écriture:
3-642-28159-1, 978-3-642-28159-4
Autres types d'écriture et termes associés:
Auteur du livre: pant, pantel, michail, klaus christ, ign, christos, sotiriou peter nikolaus mina
Titre du livre: cancer, tumors the breast, this serious one breast, mini, cel, residu, tum, min minim, minimal art, tumor, sang homericus


Données de l'éditeur

Auteur: Michail Ignatiadis; Christos Sotiriou; Klaus Pantel
Titre: Recent Results in Cancer Research; Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer
Editeur: Springer; Springer Berlin
254 Pages
Date de parution: 2012-04-23
Berlin; Heidelberg; DE
Imprimé / Fabriqué en
Langue: Anglais
160,49 € (DE)
164,99 € (AT)
177,00 CHF (CH)
POD
XIV, 254 p.

BB; Hardcover, Softcover / Medizin/Klinische Fächer; Onkologie; Verstehen; Medizin, Gesundheit; Breast cancer; Circulating nucleic acids; Circulating tumor cells; Micrometastasis; Minimal residual disease; surgical oncology; Oncology; Gynecology; Cancer Therapy; Pathology; Cancer Biology; Gynäkologie und Geburtshilfe; Pathologie; BC

Minimal residual disease and circulating tumor cells in breast cancer: Open questions for research.- Minimal residual disease and breast cancer metastasis.- Self-seeding in cancer.- Microenvironments dictating tumor cell dormancy.- Technologies for circulating tumor cell (CTC) and disseminated tumor cell (DTC) detection and characterization.- Immunomagnetic separation technologies.- Microfluidic technologies for the isolation of CTCs.- EPISPOT assay: Detection of viable disseminating tumor cells in solid tumor patients.- Advances in optical technologies for rare cell detection and characterization.- Size-based enrichment technologies for circulating tumor cell (CTC) detection and characterization.- Emerging technologies for CTC detection based on depletion of normal cells.- Molecular assays for the detection and characterization of CTCs.- Multiplex molecular analysis of CTCs.- Other blood-based biomarkers.- Circulating DNA and next generation sequencing.- Circulating microRNAs as non-invasive biomarkers in breast cancer.- Circulating endothelial cells and circulating endothelial progenitors.- Disseminated tumor cells (DTCs) and circulating tumor cells (CTCs) in breast cancer clinical research and practice.- Bone marrow DTCs.- CTCs in primary breast cancer.- CTCs in early breast cancer.- CTCs in metastatic breast cancer.- HER2-positive DTCs/CTCs in breast cancer.- DTCs and CTCs in breast cancer – 5 decades later.- Drug and circulating tumor cell co-development.- Challenges in drug and biomarker co-development.- Challenges and opportunities in the use of CTCs for companion diagnostic development.

Most deaths from carcinomas are caused by the hematogenous dissemination of cancer cells to distant organs and the eventual development of metastases. When found in the bone marrow or peripheral blood of carcinoma patients, occult cancer cells are referred to as disseminated tumor cells (DTCs) or circulating tumor cells (CTCs). CTCs and DTCs are considered surrogates of minimal residual disease, i.e., the presence of malignant cells in distant organs that are undetectable by conventional imaging and laboratory tests used for tumor staging after curative surgery of the primary tumor.

 

In this book, leading investigators in the field provide up-to-date information on a series of important questions, including:

 

-  How can the study of minimal residual disease and CTCs help us to better understand breast cancer metastasis?

-  What technologies are available for the detection and characterization of CTCs and DTCs, and what are their relative merits?

-  How are DTCs and CTCs relevant to clinical research and practice?

- What is the role of other blood-based biomarkers such as circulating endothelial cells and circulating nucleic acids?

-  What are the challenges in drug and biomarker co-development and the use of CTCs for companion diagnostic development?

 

Provides up-to-date information on topical issues concerning minimal residual disease in breast cancer patients

Appraises the technologies available for detection and characterization of circulating and disseminated tumor cells (CTCs/DTCs)

Discusses the relevance of CTCs and DTCs in breast cancer clinical research and practice, and the role of other blood-based biomarkers


Provides up-to-date information on topical issues concerning minimal residual disease in breast cancer patients Appraises the technologies available for detection and characterization of circulating and disseminated tumor cells (CTCs/DTCs) Discusses the relevance of CTCs and DTCs in breast cancer clinical research and practice, and the role of other blood-based biomarkers Includes supplementary material: sn.pub/extras

< pour archiver...